수정체 유화 시스템 시장 보고서(2025년)
Phacoemulsification System Global Market Report 2025
상품코드 : 1889536
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,684,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,662,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,639,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수정체 유화 시스템 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2024년 14억 달러에서 2025년에는 15억 1,000만 달러에 달하고, CAGR 7.8%로 확대될 것으로 전망되고 있습니다. 지난 수년간의 성장은 노화성 백내장 증례 증가, 저침습 안과 수술의 보급 확대, 세계 노인 인구 증가, 회복이 빠른 수술 방법에 대한 선호도 증가 및 첨단 안구 렌즈의 보급 확대로 인한 것으로 예측됩니다.

수정체 유화 시스템 시장 규모는 앞으로 수년간 강력한 성장이 예상됩니다. 2029년에는 20억 2,000만 달러에 달하고, CAGR은 7.4%를 나타낼 전망입니다. 예측기간의 성장요인으로는 백내장 치료법의 인지도 향상, 개발도상국에서의 의료비 지출 증가, 파코찹 기술의 지속적인 개량, 노화 시각장애의 발생률 상승, 안과의를 위한 연수 프로그램의 확충 등을 들 수 있습니다. 예측기간 중에 예상되는 주요 동향으로는 유체제어기술 및 에너지제어기술의 진보, 미세 절개 백내장 수술기술의 혁신, 파코플랫폼을 이용한 화상 진단, 가이던스 시스템의 통합, 휴대형 및 콤팩트형 수정체 유화 장치의 개발, 펨토초 레이저 보조 렌즈 적출 워크플로의 혁신 등을 들 수 있습니다.

향후 수정체 유화 시스템 시장의 성장을 견인할 것으로 예상되는 것은 저침습 안과 수술의 채용 확대입니다. 저침습 안과 수술은 작은 절개, 마이크로기구 또는 레이저를 사용하는 기술로 조직 손상을 최소화하면서 안 질환을 진단하고 치료하는 고급 안과 의료 기술을 말합니다. 저침습 안과 수술은 회복 기간의 단축을 요구하는 경향 증가로 인해 증가하고 있습니다. 이 기술은 수술로 인한 외상을 줄이고 환자가 일상 생활에 더 빨리 복귀할 수 있도록 합니다. 수정체 유화 시스템은 초음파 에너지를 이용하여 작은 절개부에서 백내장을 파쇄, 제거함으로써 저침습 안과 수술을 지원하여 치유 촉진, 조직 손상 저감, 수술 정밀도 향상을 실현합니다. 예를 들어 영국 정부 기관인 Gov.UK에 따르면 2024년 5월 영국에서 65세 이상의 백내장 수술로 인한 입원 환자 수는 516,073명으로 2023년 인구 10만명당 4,679명의 비율을 보였습니다. 따라서 저침습 안과 수술의 보급 확대가 수정체 유화 시스템 시장의 성장을 견인하고 있습니다.

수정체 유화 시스템 시장에서 사업을 전개하는 주요 기업은 펨토초 레이저 기술의 통합에 주력하고 있습니다. 구체적으로는 안압(IOP)을 안정적으로 유지하고 전방의 안정성을 높여 백내장 수술의 전 단계를 통해 일관된 유체 제어를 보장하는 선진적인 유체 제어 기술 등으로 수술의 정확성과 환자의 안전성을 향상시키고 있습니다. 첨단 유체 제어 기술은 안과 수술 중 관류와 흡입의 균형을 정밀하게 조절하는 수정체 유화 시스템의 유체 관리 기술을 말합니다. 예를 들어, 2025년 9월에는 미국에 본사를 둔 안과 의료기기 제조업체인 비버 비지텍 인터내셔널사(BVI)가 백내장 수술과 유리체 망막 수술 모두에 대응하는 듀얼 기능형 수정체 유화 유리체 절제 수술 플랫폼 'Virtuoso'를 발표했습니다. 본 시스템에는 모든 수술 공정에서 목표 안압(IOP)을 유지하는 혁신적인 유체 제어 기술, 방수 안정성을 향상시키는 하이브리드 유량, 압력 펌프 설계, 수정체의 저항에 따라 초음파 에너지를 자동 조정하여 정밀도와 수술 효율을 높이는 부하 감지형 파코 기술(Load Sensing Phaco)이 탑재되어 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Phacoemulsification systems are advanced medical devices that use ultrasonic energy to break up and remove the eye's natural lens during cataract surgery, enabling the placement of an artificial intraocular lens (IOL) to restore clear vision. They are engineered to deliver precise control over fluidics, pressure, and energy output, ensuring safety, efficiency, and optimal surgical performance.

The primary product types of phacoemulsification systems include standalone phacoemulsification systems and portable phacoemulsification systems. Standalone phacoemulsification systems are fully integrated, stationary surgical units designed specifically for carrying out phacoemulsification procedures in ophthalmology. These systems employ various technologies-such as ultrasound, femtosecond laser, and others-to support a wide range of ophthalmic treatments. Key disease indications include cataract, presbyopia, glaucoma, and additional conditions. The primary applications for these systems are cataract surgery, refractive surgery, and other related procedures. They are utilized across multiple end users, including hospitals, ophthalmic clinics, ambulatory surgical centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The phacoemulsification systems market research report is one of a series of new reports from The Business Research Company that provides phacoemulsification systems market statistics, including phacoemulsification systems industry global market size, regional shares, competitors with a phacoemulsification systems market share, detailed phacoemulsification systems market segments, market trends and opportunities, and any further data you may need to thrive in the phacoemulsification systems industry. This phacoemulsification systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The phacoemulsification system market size has grown strongly in recent years. It will grow from $1.40 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. Growth in the historic period can be attributed to increasing cases of age-related cataracts, rising adoption of minimally invasive eye surgeries, a growing global geriatric population, increasing preference for faster-recovery surgical methods, and expanding availability of advanced intraocular lenses.

The phacoemulsification system market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. Growth in the forecast period can be attributed to rising awareness of cataract treatment options, increasing healthcare spending in developing countries, ongoing improvements in ultrasound-based phaco technologies, a growing incidence of age-related vision disorders, and expanding training programs for ophthalmic surgeons. Major trends expected in the forecast period include advancements in fluidics and energy-control technologies, innovations in micro-incision cataract surgery techniques, integration of imaging and guidance systems into phaco platforms, development of portable and compact phacoemulsification devices, and innovations in femtosecond-assisted lens removal workflows.

The increasing adoption of minimally invasive ophthalmic procedures is expected to propel the growth of the phacoemulsification system market going forward. Minimally invasive ophthalmic procedures refer to advanced eye care techniques that use small incisions, micro-instruments, or laser-based approaches to diagnose or treat eye conditions with minimal tissue disruption. The rise in minimally invasive ophthalmic procedures is due to the growing preference for faster recovery, as these techniques reduce surgical trauma and allow patients to resume daily activities much sooner. Phacoemulsification systems support minimally invasive ophthalmic procedures by using ultrasonic energy to break and remove the cataract through a tiny incision, enabling faster healing, reduced tissue damage, and improved surgical precision. For instance, in May 2024, according to Gov.UK, a UK-based government agency, there were 516,073 hospital admissions in England for cataract surgery among individuals aged 65 and above, representing a rate of 4,679 per 100,000 population in 2023. Therefore, the increasing adoption of minimally invasive ophthalmic procedures is driving the growth of the phacoemulsification system market.

Key companies operating in the phacoemulsification system market are focusing on integrating femtosecond laser technology, such as advanced fluidics concepts that maintain stable intraocular pressure (IOP), enhance chamber stability, and ensure consistent fluid control throughout all phases of cataract surgery, thereby improving surgical precision and patient safety. Advanced fluidics concepts refer to fluid management technologies in phacoemulsification systems that precisely regulate the balance between irrigation and aspiration during eye surgery. For instance, in September 2025, Beaver-Visitec International, Inc. (BVI), a US-based ophthalmic medical device company, introduced Virtuoso, a dual-function phaco-vitrectomy surgical platform designed for both cataract and vitreoretinal procedures. The system includes an innovative fluidics concept that maintains target intraocular pressure (IOP) during all surgical steps, a hybrid flow and pressure pump design for improved chamber stability, and Load Sensing Phaco technology that automatically adjusts ultrasound energy based on lens resistance to improve precision and surgical efficiency.

In January 2024, Rayner Group, a UK-based ophthalmic technology company, acquired This AG for an undisclosed amount. Through this acquisition, Rayner aims to strengthen its cataract-surgery portfolio by integrating advanced phaco-emulsification capabilities and expanding its presence in global surgical ophthalmology. This AG is a Switzerland-based ophthalmic technology company that develops phacoemulsification systems.

Major companies operating in the phacoemulsification system market are Alcon Inc., HOYA Corporation, Bausch + Lomb Corporation, Johnson & Johnson Vision, Carl Zeiss Meditec AG, Appasamy Associates Private Limited, STAAR Surgical company, BEAVER-Visitec International, Inc., Aurolab, Rayner Intraocular Lenses Ltd., Rumex International BV, MicroSurgical Technology, Inc., D.O.R.C. International BV, LIGHTMED Corporation, Biotech Visioncare Pvt Ltd, Oertli Instrumente AG, Geuder AG, NIDEK Co., Ltd., Optikon S.p.A., MTP Medical Technical Products AG

North America was the largest region in the phacoemulsification system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in phacoemulsification systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the phacoemulsification systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The phacoemulsification systems market consists of sales of surgical equipment, consoles, handpieces, tubing sets, cassettes, and irrigation or aspiration components. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Phacoemulsification System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on phacoemulsification system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for phacoemulsification system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The phacoemulsification system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Phacoemulsification System Market Characteristics

3. Phacoemulsification System Market Trends And Strategies

4. Phacoemulsification System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Phacoemulsification System Growth Analysis And Strategic Analysis Framework

6. Phacoemulsification System Market Segmentation

7. Phacoemulsification System Market Regional And Country Analysis

8. Asia-Pacific Phacoemulsification System Market

9. China Phacoemulsification System Market

10. India Phacoemulsification System Market

11. Japan Phacoemulsification System Market

12. Australia Phacoemulsification System Market

13. Indonesia Phacoemulsification System Market

14. South Korea Phacoemulsification System Market

15. Western Europe Phacoemulsification System Market

16. UK Phacoemulsification System Market

17. Germany Phacoemulsification System Market

18. France Phacoemulsification System Market

19. Italy Phacoemulsification System Market

20. Spain Phacoemulsification System Market

21. Eastern Europe Phacoemulsification System Market

22. Russia Phacoemulsification System Market

23. North America Phacoemulsification System Market

24. USA Phacoemulsification System Market

25. Canada Phacoemulsification System Market

26. South America Phacoemulsification System Market

27. Brazil Phacoemulsification System Market

28. Middle East Phacoemulsification System Market

29. Africa Phacoemulsification System Market

30. Phacoemulsification System Market Competitive Landscape And Company Profiles

31. Phacoemulsification System Market Other Major And Innovative Companies

32. Global Phacoemulsification System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Phacoemulsification System Market

34. Recent Developments In The Phacoemulsification System Market

35. Phacoemulsification System Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기